Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-08-27FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic mirtazapine product from Mylan Pharmaceuticals Inc., confirming continued approval of …
-
FDA approval · 2015-08-26FDA Approved: DULOXETINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic duloxetine product (ANDA 203197), establishing a generic version of…
-
FDA approval · 2015-08-21FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, providing a generic version of the antips…
-
FDA approval · 2015-08-14FDA Approved: ARIPIPRAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for aripiprazole (ARIPIPRAZOLE), enabling the marketing of a generic version of this antipsychotic.
-
FDA approval · 2015-07-15FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Nortriptyline Hydrochloride from Dr. Reddy's Laboratories Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-29FDA Approved: DESVENLAFAXINE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's original application for desvenlafaxine (generic), enabling a generic version of the antidepressant.
-
FDA approval · 2015-06-29FDA Approved: DESVENLAFAXINE SUCCINATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic desvenlafaxine succinate in an Original Application (ANDA 204172) for the treatment of major dep…
-
FDA approval · 2015-06-29FDA Approved: DESVENLAFAXINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' original application for desvenlafaxine succinate (desvenlafaxine) as a generic antidepressant.
-
FDA approval · 2015-06-25FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for escitalopram (generic) under an ANDA, confirming the availability of a gene…
-
FDA approval · 2015-06-17FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for mirtazapine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-06-15FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride from Oxford Pharmaceuticals, LLC, indicating an approved modification to…
-
FDA approval · 2015-06-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Actavis) to continue marketing the generic product.
-
FDA approval · 2015-06-11FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA has approved Allergan's supplemental application for VIIBRYD (vilazodone hydrochloride), granting approval for the requested change …
-
FDA approval · 2015-06-09FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for sertraline hydrochloride (generic) from Quallent Pharmaceuticals Health LLC under ANDA077397.
-
FDA approval · 2015-06-05FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) from Allergan, Inc.
-
FDA approval · 2015-06-02FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride submitted by Apotex Corp.
-
FDA approval · 2015-05-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved Yaopharma Co., Ltd.'s original application for venlafaxine hydrochloride, authorizing a new generic version of the antidepressa…
-
FDA approval · 2015-05-26FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Solco Healthcare US LLC)
FDA approval of a generic Bupropion Hydrochloride sustained-release tablet (Solco Healthcare US LLC).
-
FDA approval · 2015-05-16FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Apnar Pharma LP's generic Bupropion hydrochloride, confirming approval to market the product wit…
-
FDA approval · 2015-05-14FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC, indicating approval of a supplemental gene…
-
FDA approval · 2015-05-12FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride from Oxford Pharmaceuticals, LLC.
-
FDA approval · 2015-05-12FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride submitted by Oxford Pharmaceuticals, LLC.
-
FDA approval · 2015-05-01FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2015-04-28FDA Approved: ARIPIPRAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic's original ANDA for aripiprazole, a generic version of the antipsychotic.
-
FDA approval · 2015-04-28FDA Approved: ARIPIPRAZOLE — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approved a generic aripiprazole tablet under ANDA205064 for Exelan Pharmaceuticals, authorizing sale for the same indications as the bra…